Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma.

Cury SS, Lapa RML, de Mello JBH, Marchi FA, Domingues MAC, Pinto CAL, Carvalho RF, de Carvalho GB, Kowalski LP, Rogatto SR.

Oral Oncol. 2020 Feb 19;103:104592. doi: 10.1016/j.oraloncology.2020.104592. [Epub ahead of print]

PMID:
32087405
2.

DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions.

Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR.

Thyroid. 2019 Sep;29(9):1244-1254. doi: 10.1089/thy.2018.0458. Epub 2019 Aug 16.

PMID:
31328658
3.

Circulating mRNA Signature as a Marker for High-Risk Prostate Cancer.

Souza MF, Kuasne H, Barros-Filho MC, Cilião HL, Marchi FA, Fuganti PE, Rogatto SR, Cólus IMS.

Carcinogenesis. 2019 Jul 13. pii: bgz129. doi: 10.1093/carcin/bgz129. [Epub ahead of print]

PMID:
31305891
4.

High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data.

Gomig THB, Cavalli IJ, Souza RLR, Lucena ACR, Batista M, Machado KC, Marchini FK, Marchi FA, Lima RS, Urban CA, Cavalli LR, Ribeiro EMSF.

Data Brief. 2019 Jun 10;25:104125. doi: 10.1016/j.dib.2019.104125. eCollection 2019 Aug.

5.

Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response.

Canto LMD, Cury SS, Barros-Filho MC, Kupper BEC, Begnami MDFS, Scapulatempo-Neto C, Carvalho RF, Marchi FA, Olsen DA, Madsen JS, Havelund BM, Aguiar S Jr, Rogatto SR.

Sci Rep. 2019 Jun 18;9(1):8702. doi: 10.1038/s41598-019-45151-w.

6.

Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.

Lapa RML, Barros-Filho MC, Marchi FA, Domingues MAC, de Carvalho GB, Drigo SA, Kowalski LP, Rogatto SR.

Oral Oncol. 2019 Jun;93:76-84. doi: 10.1016/j.oraloncology.2019.04.018. Epub 2019 Apr 29.

7.

Rab5C enhances resistance to ionizing radiation in rectal cancer.

Baptistella AR, Landemberger MC, Dias MVS, Giudice FS, Rodrigues BR, da Silva PPCE, Cassinela EK, Lacerda TC, Marchi FA, Leme AFP, Begnami MD, Aguiar S Jr, Martins VR.

J Mol Med (Berl). 2019 Jun;97(6):855-869. doi: 10.1007/s00109-019-01760-6. Epub 2019 Apr 9.

PMID:
30968159
8.

Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer.

Laufer-Amorim R, Fonseca-Alves CE, Villacis RAR, Linde SAD, Carvalho M, Larsen SJ, Marchi FA, Rogatto SR.

Int J Mol Sci. 2019 Mar 28;20(7). pii: E1555. doi: 10.3390/ijms20071555.

9.

Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.

Gomig THB, Cavalli IJ, Souza RLR, Vieira E, Lucena ACR, Batista M, Machado KC, Marchini FK, Marchi FA, Lima RS, de Andrade Urban C, Cavalli LR, Ribeiro EMSF.

J Proteomics. 2019 May 15;199:1-14. doi: 10.1016/j.jprot.2019.02.007. Epub 2019 Feb 14.

PMID:
30772490
10.

Prostaglandin D2 expression is prognostic in high‑grade serous ovarian cancer.

Alves MR, Do Amaral NS, Marchi FA, Silva FIB, Da Costa AABA, Carvalho KC, Baiocchi G, Soares FA, De Brot L, Rocha RM.

Oncol Rep. 2019 Apr;41(4):2254-2264. doi: 10.3892/or.2019.6984. Epub 2019 Jan 28.

PMID:
30720106
11.

Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.

Ortiz IMDP, Barros-Filho MC, Dos Reis MB, Beltrami CM, Marchi FA, Kuasne H, do Canto LM, de Mello JBH, Abildgaard C, Pinto CAL, Kowalski LP, Rogatto SR.

Clin Epigenetics. 2018 Nov 20;10(1):144. doi: 10.1186/s13148-018-0579-8.

12.

TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.

da Silva SD, Xu B, Maschietto M, Marchi FA, Alkailani MI, Bijian K, Xiao D, Alaoui-Jamali MA.

Mol Cancer Ther. 2019 Jan;18(1):139-146. doi: 10.1158/1535-7163.MCT-17-1261. Epub 2018 Oct 29.

13.

Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer.

Carnielli CM, Macedo CCS, De Rossi T, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Calone I, Meirelles GV, Marchi FA, Telles GP, Minghim R, Ribeiro ACP, Brandão TB, de Castro G Jr, González-Arriagada WA, Gomes A, Penteado F, Santos-Silva AR, Lopes MA, Rodrigues PC, Sundquist E, Salo T, da Silva SD, Alaoui-Jamali MA, Graner E, Fox JW, Coletta RD, Paes Leme AF.

Nat Commun. 2018 Sep 5;9(1):3598. doi: 10.1038/s41467-018-05696-2.

14.

Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor.

Kuasne H, Barros-Filho MC, Marchi FA, Drigo SA, Scapulatempo-Neto C, Faria EF, Rogatto SR.

Virchows Arch. 2018 Nov;473(5):607-614. doi: 10.1007/s00428-018-2404-3. Epub 2018 Aug 11.

PMID:
30099587
15.

Oncogenic drivers in 11q13 associated with prognosis and response to therapy in advanced oropharyngeal carcinomas.

Barros-Filho MC, Reis-Rosa LA, Hatakeyama M, Marchi FA, Chulam T, Scapulatempo-Neto C, Nicolau UR, Carvalho AL, Pinto CAL, Drigo SA, Kowalski LP, Rogatto SR.

Oral Oncol. 2018 Aug;83:81-90. doi: 10.1016/j.oraloncology.2018.06.010. Epub 2018 Jun 15.

PMID:
30098783
16.

Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.

Bisarro Dos Reis M, Barros-Filho MC, Marchi FA, Beltrami CM, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099. doi: 10.1210/jc.2017-00881.

17.

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.

Souza MF, Kuasne H, Barros-Filho MC, Cilião HL, Marchi FA, Fuganti PE, Paschoal AR, Rogatto SR, Cólus IMS.

PLoS One. 2017 Sep 14;12(9):e0184094. doi: 10.1371/journal.pone.0184094. eCollection 2017.

18.

Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.

Marchi FA, Martins DC, Barros-Filho MC, Kuasne H, Busso Lopes AF, Brentani H, Trindade Filho JCS, Guimarães GC, Faria EF, Scapulatempo-Neto C, Lopes A, Rogatto SR.

Sci Rep. 2017 Jul 27;7(1):6707. doi: 10.1038/s41598-017-06659-1.

19.

Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.

Beltrami CM, Dos Reis MB, Barros-Filho MC, Marchi FA, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR.

Clin Epigenetics. 2017 May 2;9:45. doi: 10.1186/s13148-017-0346-2. eCollection 2017.

20.

HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.

Pinheiro M, Drigo SA, Tonhosolo R, Andrade SCS, Marchi FA, Jurisica I, Kowalski LP, Achatz MI, Rogatto SR.

Oncotarget. 2017 Jun 20;8(25):40896-40905. doi: 10.18632/oncotarget.16639.

21.

Genomic copy number variation associated with clinical outcome in canine cutaneous mast cell tumors.

Jark PC, Mundin DB, de Carvalho M, Ferioli RB, Anai LA, Marchi FA, Rogatto SR, Laufer-Amorim R, Tinucci-Costa M.

Res Vet Sci. 2017 Apr;111:26-30. doi: 10.1016/j.rvsc.2016.11.009. Epub 2016 Nov 17.

PMID:
28266316
22.

Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact.

Kuasne H, Barros-Filho MC, Busso-Lopes A, Marchi FA, Pinheiro M, Muñoz JJ, Scapulatempo-Neto C, Faria EF, Guimarães GC, Lopes A, Trindade-Filho JC, Domingues MA, Drigo SA, Rogatto SR.

Oncotarget. 2017 Feb 28;8(9):15294-15306. doi: 10.18632/oncotarget.14783.

23.

Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.

Canevari RA, Marchi FA, Domingues MA, de Andrade VP, Caldeira JR, Verjovski-Almeida S, Rogatto SR, Reis EM.

Tumour Biol. 2016 Oct;37(10):13855-13870. Epub 2016 Aug 2.

PMID:
27485113
24.

An Integrative Approach Uncovers Biomarkers that Associate with Clinically Relevant Disease Outcomes in Vulvar Carcinoma.

Lavorato-Rocha AM, Akagi EM, de Melo Maia B, Rodrigues IS, Botelho MC, Marchi FA, Fernandes G, Baiocchi G, Soares FA, Rogatto SR, Sato-Kuwabara Y, Rocha RM.

Mol Cancer Res. 2016 Aug;14(8):720-9. doi: 10.1158/1541-7786.MCR-15-0366. Epub 2016 May 11.

25.

A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma.

Muñoz JJ, Drigo SA, Kuasne H, Villacis RA, Marchi FA, Domingues MA, Lopes A, Santos TG, Rogatto SR.

Tumour Biol. 2016 Aug;37(8):11375-84. doi: 10.1007/s13277-016-4951-z. Epub 2016 Mar 10.

PMID:
26960831
26.

Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions.

Voorwald FA, Marchi FA, Villacis RA, Alves CE, Toniollo GH, Amorim RL, Drigo SA, Rogatto SR.

PLoS One. 2015 Jul 29;10(7):e0133894. doi: 10.1371/journal.pone.0133894. eCollection 2015.

27.

Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.

da Silva SD, Marchi FA, Xu B, Bijian K, Alobaid F, Mlynarek A, Rogatto SR, Hier M, Kowalski LP, Alaoui-Jamali MA.

Oncotarget. 2015 Sep 8;6(26):21950-63.

28.

DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.

Fortes FP, Kuasne H, Marchi FA, Miranda PM, Rogatto SR, Achatz MI.

Braz J Med Biol Res. 2015 Jul;48(7):610-5. doi: 10.1590/1414-431X20154026. Epub 2015 Apr 28.

29.

Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.

Kuasne H, Cólus IM, Busso AF, Hernandez-Vargas H, Barros-Filho MC, Marchi FA, Scapulatempo-Neto C, Faria EF, Lopes A, Guimarães GC, Herceg Z, Rogatto SR.

Clin Epigenetics. 2015 Apr 18;7:46. doi: 10.1186/s13148-015-0082-4. eCollection 2015.

30.

High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.

Barros-Filho MC, Marchi FA, Pinto CA, Rogatto SR, Kowalski LP.

J Clin Endocrinol Metab. 2015 Jun;100(6):E890-9. doi: 10.1210/jc.2014-4053. Epub 2015 Apr 13.

PMID:
25867809
31.

Genomic profiling of human penile carcinoma predicts worse prognosis and survival.

Busso-Lopes AF, Marchi FA, Kuasne H, Scapulatempo-Neto C, Trindade-Filho JC, de Jesus CM, Lopes A, Guimarães GC, Rogatto SR.

Cancer Prev Res (Phila). 2015 Feb;8(2):149-56. doi: 10.1158/1940-6207.CAPR-14-0284. Epub 2014 Dec 10.

32.

Down-Regulation of SLC8A1 as a Putative Apoptosis Evasion Mechanism by Modulation of Calcium Levels in Penile Carcinoma.

Muñoz JJ, Drigo SA, Barros-Filho MC, Marchi FA, Scapulatempo-Neto C, Pessoa GS, Guimarães GC, Trindade Filho JC, Lopes A, Arruda MA, Rogatto SR.

J Urol. 2015 Jul;194(1):245-51. doi: 10.1016/j.juro.2014.11.097. Epub 2014 Dec 3.

PMID:
25481039
33.

Genomic screening of testicular germ cell tumors from monozygotic twins.

Silveira SM, da Cunha IW, Marchi FA, Busso AF, Lopes A, Rogatto SR.

Orphanet J Rare Dis. 2014 Nov 26;9:181. doi: 10.1186/s13023-014-0181-x.

34.

Genome-wide DNA methylation profile of leukocytes from melanoma patients with and without CDKN2A mutations.

de Araújo É, Marchi FA, Rodrigues TC, Vieira HC, Kuasne H, Achatz MI, Moredo LF, de Sá BC, Duprat JP, Brentani HP, Rosenberg C, Carraro DM, Krepischi AC.

Exp Mol Pathol. 2014 Dec;97(3):425-32. doi: 10.1016/j.yexmp.2014.09.009. Epub 2014 Sep 16.

35.

Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival.

Lopes MH, Santos TG, Rodrigues BR, Queiroz-Hazarbassanov N, Cunha IW, Wasilewska-Sampaio AP, Costa-Silva B, Marchi FA, Bleggi-Torres LF, Sanematsu PI, Suzuki SH, Oba-Shinjo SM, Marie SK, Toulmin E, Hill AF, Martins VR.

Oncogene. 2015 Jun;34(25):3305-14. doi: 10.1038/onc.2014.261. Epub 2014 Aug 25.

PMID:
25151961
36.

Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.

Villacis RA, Silveira SM, Barros-Filho MC, Marchi FA, Domingues MA, Scapulatempo-Neto C, Aguiar S Jr, Lopes A, Cunha IW, Rogatto SR.

PLoS One. 2014 Jul 16;9(7):e102281. doi: 10.1371/journal.pone.0102281. eCollection 2014.

37.

Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.

Silveira SM, Villacis RA, Marchi FA, Barros Filho Mde C, Drigo SA, Neto CS, Lopes A, da Cunha IW, Rogatto SR.

PLoS One. 2013 Jun 25;8(6):e67643. doi: 10.1371/journal.pone.0067643. Print 2013.

38.

Epigenetic mechanisms in penile carcinoma.

Kuasne H, Marchi FA, Rogatto SR, de Syllos Cólus IM.

Int J Mol Sci. 2013 May 23;14(6):10791-808. doi: 10.3390/ijms140610791. Review.

39.

An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas.

Cirilo PD, Marchi FA, Barros Filho Mde C, Rocha RM, Domingues MA, Jurisica I, Pontes A, Rogatto SR.

PLoS One. 2013;8(3):e57901. doi: 10.1371/journal.pone.0057901. Epub 2013 Mar 4.

Supplemental Content

Loading ...
Support Center